Hubei Chenxin Pharmaceutical

Hubei Chenxin Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise headquartered in Wuhan, China, specializing in the research, development, production, and export of active pharmaceutical ingredients (APIs) and chemical intermediates. The company maintains a diverse portfolio of products spanning multiple therapeutic areas, including cardiovascular health, oncology, and infectious diseases, with key offerings such as Atorvastatin, Afatinib, and various semi-synthetic antibiotics. Hubei Chenxin operates as a professional manufacturer and supplier, collaborating with academic institutions like the Hubei University of Chinese Medicine to ensure high-quality standards and technical progress. Its business model focuses on providing high-purity raw materials to the global pharmaceutical industry, supported by a scientific quality management system and a commitment to environmental protection.